Skip to content

Application Study of Infusing Irritant Medications Through Midline Catheter Based on Real World Study

Application Study of Infusing Irritant Medications Through Midline Catheter Based on Real World Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05710835
Enrollment
1500
Registered
2023-02-02
Start date
2022-12-01
Completion date
2024-06-30
Last updated
2023-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter Complications

Brief summary

The goal of this observational study is to learn about the effect on midline catheter outcomes when infusing irritant medications through midline catheter. The main questions it aims to answer are:Identify the current situation of infusing irritant medications through midline catheter;Explore the effect on midline catheter outcomes when infusing irritant medications through midline catheter;Identify specific medications that affect catheter outcomes.

Detailed description

First, the patients were divided into two groups according to whether irritant medications were infused or not,then observed the rate of complications between the two groups.Second, grouped according to the irritant medications, Identify specific medications that affect catheter outcomes through statistical analysis.

Interventions

None listed

Sponsors

Sir Run Run Shaw Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥14 years old * Patients who had a midline catheter

Exclusion criteria

* Patients who received vesicant medications through the midline catheter * Patients who had both a midline catheter and a central vascular access device

Design outcomes

Primary

MeasureTime frameDescription
catheter complicationsduring catheter indwellingcatheter complications rate

Countries

China

Contacts

Primary ContactLinfang Zhao
3193159@zju.edu.cn13588819123
Backup ContactXiuzhu Cao
Caoxz@srrsh.com13588477316

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026